Quadrature Capital’s Pulmonx LUNG Stock Holding History

Quadrature Capital’s Portfolio LUNG Stock Details LUNG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-32,876	Closed	-$53.4K	–	1497
2025 Q3	$53.4K	Buy	+32,876	New	+$68.8K	﹤0.01%	952

Other funds holding LUNG

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

ECM

ExodusPoint Capital Management New York $12.6B AUM 30.13% 1-Year Est. Return

SAM

Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Quadrature Capital's LUNG Position: Q4 2025 in Review

Quadrature Capital sold out of Pulmonx (LUNG) in Q4 2025, closing a stake of 32,876 shares — an estimated $53.4K sold.

Quadrature Capital first reported a position in LUNG in Q3 2025 and held it in 1 quarter. The position peaked at $53.4K in Q3 2025. 112 funds tracked by Wall St. Rank hold LUNG as of Q4 2025.

Quadrature Capital reported no remaining Pulmonx position as of Q4 2025 after selling out during the quarter.
Quadrature Capital sold 32,876 Pulmonx shares in Q4 2025, an estimated $53.4K.
Quadrature Capital first reported a position in Pulmonx in Q3 2025 and held it in 1 quarter.
Quadrature Capital's Pulmonx position peaked at $53.4K in Q3 2025.
112 funds tracked by Wall St. Rank held Pulmonx as of Q4 2025.

Based on Quadrature Capital's 13F filing for Q4 2025, filed 17 Feb 2026.